Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)Pamela L Kunz, Noah T Graham, Paul J Catalano, et al.The New England Journal of Medicine|September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsJennifer A Chan, Susan Geyer, Tyler Zemla, et al.The Lancet. Oncology|August 26, 2017
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialMarianne E Pavel, Simron Singh, Jonathan R Strosberg, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2019
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic CancerAna Babic, Michael H Rosenthal, William R Bamlet, et al.Neuroendocrinology|July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine TumoursEric Raymond, Matthew H Kulke, Shukui Qin, et al.Critical Care Medicine|June 11, 2021
Validation of a Crisis Standards of Care Model for Prioritization of Limited Resources During the Coronavirus Disease 2019 Crisis in an Urban, Safety-Net, Academic Medical CenterAlbert Nadjarian, Jessica LeClair, Taylor F Mahoney, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Neuroendocrine tumors, version 1.2015Matthew H Kulke, Manisha H Shah, Al B Benson, et al.Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.Nature Medicine|September 11, 2019
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumorsPaloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.Pageof 19